Live Chat ×
Skip to main content

The Role of CDER Genomics and Targeted Therapy Group in Maximizing the Impact of Individualized Therapy

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Michael Pacanowski, Ph.D.

    Dr. Pacanowski is the Associate Director for Genomics and Targeted Therapy in FDA’s Office of Clinical Pharmacology.His team of translational scientists works across all therapeutic areas to advance the practice of precision medicine by (1) advising drug, biomarker, and in vitro diagnostic developers on scientific and regulatory matters; (2) developing policies and guidance for industry related to pharmacogenomics and targeted drug development; and (3) conducting research projects to evaluate the use biomarkers in drug development and regulatory decision-making.Dr. Pacanowski received his Pharm.D. from the University of the Sciences in Philadelphia (2004) and his M.P.H. from the University of Florida (2008). He completed a residency in clinical pharmacology at Bassett Healthcare in Cooperstown, NY (2005), and a clinical research fellowship in cardiovascular pharmacogenomics at the University of Florida (2008).

September 6, 2018
Thu 12:30 PM EDT

Duration 1H 30M

This live web event has ended.